Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 6.725.865.464.847.72

What is the latest EV/Core EBITDA ratio of BLISS GVS PHARMA ?

The latest EV/Core EBITDA ratio of BLISS GVS PHARMA is 6.72 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20256.72
Mar20245.86
Mar20235.46
Mar20224.84
Mar20217.72

How is EV/Core EBITDA of BLISS GVS PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 6.72
14.68
Mar2024 5.86
7.33
Mar2023 5.46
12.81
Mar2022 4.84
-37.31
Mar2021 7.72 -

Other Financial Ratios of BLISS GVS PHARMA


Compare EV/Core EBITDA ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,792.1 Cr 1.7% 9.3% 32.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,370.0 Cr 1.2% 5.5% 0.3% Stock Analytics
DIVIS LABORATORIES ₹168,802.0 Cr -1.8% -3.1% 8.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,841.0 Cr -2% 2.8% 19.2% Stock Analytics
CIPLA ₹121,481.0 Cr -0.7% -8.6% 2.7% Stock Analytics
DR REDDYS LABORATORIES ₹102,220.0 Cr -1.5% -4.3% 2.5% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

1.7%

9.3%

32.4%

SENSEX

-0.1%

0.6%

9.8%


You may also like the below Video Courses